Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts - PubMed

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

A B Cosimi et al. N Engl J Med. 1981.

Abstract

Using monoclonal antibodies and flow cytometry, wer serially monitored lymphocyte subpopulations in renal-allograft recipients treated with either conventional immunosuppression or a monoclonal antibody. In 29 patients given conventional suppression, highly significant correlations between changes in T-cell subsets and rejection were noted. Normal or elevated ratios of OKT4 (helper/inducer) to OKT8 (suppressor/cytotoxic) cells were associated with rejection unless the donor was HLA identical or the total number of T cells was extremely low. In patients with low ratios, rejection seldom occurred. Two patients treated with OKT3 monoclonal antibody for acute rejection had rapid disappearance of OKT3-reactive cells from the peripheral blood and prompt reversal of rejection. The use of monoclonal antibodies allows the precise determination of changes in T-cell subsets and promises the development of therapeutic protocols that can be designed to manipulate selected lymphocyte populations.

Similar articles

• Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.

  Burton RC, Cosimi AB, Colvin RB, Rubin RH, Delmonico FL, Goldstein G, Russell PS. Burton RC, et al. J Clin Immunol. 1982 Jul;2(3 Suppl):142S-147S. J Clin Immunol. 1982. PMID: 6290526

• Immunologic monitoring with Orthoclone OKT3 therapy.

  Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB. Schroeder TJ, et al. J Heart Transplant. 1989 Sep-Oct;8(5):371-80. J Heart Transplant. 1989. PMID: 2529358

• Monoclonal antibodies for the diagnosis and treatment of transplant rejection.

  Russell PS, Colvin RB, Cosimi AB. Russell PS, et al. Annu Rev Med. 1984;35:63-81. doi: 10.1146/annurev.me.35.020184.000431. Annu Rev Med. 1984. PMID: 6372674 Review.

• Monoclonal antibody treatment of human allograft recipients.

  Delmonico FL, Cosimi AB. Delmonico FL, et al. Surg Gynecol Obstet. 1988 Jan;166(1):89-98. Surg Gynecol Obstet. 1988. PMID: 3276014 Review.

Cited by

• Historical overview of transplantation.

  Barker CF, Markmann JF. Barker CF, et al. Cold Spring Harb Perspect Med. 2013 Apr 1;3(4):a014977. doi: 10.1101/cshperspect.a014977. Cold Spring Harb Perspect Med. 2013. PMID: 23545575 Free PMC article.

• Prognostic value of T lymphocyte subset ratios for renal transplant survival in patients on different immunosuppressive regimens.

  Henny FC, van Es A, Oljans PJ, Baldwin WM, Tanke HJ, van Es LA, Paul LC. Henny FC, et al. Clin Exp Immunol. 1986 Aug;65(2):373-80. Clin Exp Immunol. 1986. PMID: 3024886 Free PMC article.

• Clinical applications of monoclonal antibodies.

  Krakauer H. Krakauer H. Eur J Clin Microbiol. 1985 Feb;4(1):1-9. doi: 10.1007/BF02148651. Eur J Clin Microbiol. 1985. PMID: 3886376 Review.

• T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

  Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. Miethke T, et al. J Exp Med. 1992 Jan 1;175(1):91-8. doi: 10.1084/jem.175.1.91. J Exp Med. 1992. PMID: 1730929 Free PMC article.

• Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

  Fung JJ, Demetris AJ, Porter KA, Iwatsuki S, Gordon RD, Esquivel CO, Jaffe R, Tzakis A, Shaw BW Jr, Starzl TE. Fung JJ, et al. Nephron. 1987;46 Suppl 1(Suppl 1):19-33. doi: 10.1159/000184431. Nephron. 1987. PMID: 3306422 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program